By acquiring T3 Pharma, a leader in bacterial cancer treatment, Boehringer Ingelheim broadens its offering in immunooncology.

Published Date: 27 Nov 2023

Germany: T3 Pharmaceuticals AG, a privately held clinical stage Swiss biotech company, has been acquired by Boehringer Ingelheim for an $.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Drop in credit score after cancer diagnosis linked to increased mortality

2.

Acupuncture may alleviate nocturia in men treated for prostate cancer

3.

The use of biomarkers in the treatment of breast lumps is at a crossroads.

4.

Formaldehyde Causes More Cancer Than Any Other Toxic Air Pollutant

5.

Where Did This Very Painful Gluteal Mass Come From?


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot